The Prognostic Factors of Bloodstream Infection in Immunosuppressed Elderly Patients: A Retrospective, Single-center, Five-year Cohort Study

References

• Lin H, Yang L, Fang J, et al. Clinical characteristics of bloodstream infection in immunosuppressed patients: a 5-year retrospective cohort study. Front Cell Infect Microbiol. 2022;12:796656. doi:10.3389/fcimb.2022.796656
   PubMed Web of Science ®Google Scholar
• Cavaillon JM, Giamarellos-Bourboulis EJ. Immunosuppression is inappropriately qualifying the immune status of septic and SIRS patients. Shock. 2019;52(3):307–317. doi:10.1097/SHK.0000000000001266
   Web of Science ®Google Scholar
• Si X, Ji G, Ma S, et al. In-situ-sprayed dual-functional immunotherapeutic gel for colorectal cancer postsurgical treatment. Adv Healthc Mater. 2021;10(20):e2100862. doi:10.1002/adhm.202100862
   Web of Science ®Google Scholar
• Shipman P, Highland J, Witt B, Alt J. Non-invasive fungal sinusitis as a complication of a steroid-eluting stent following endoscopic sinus surgery: a case report. Ann Otol Rhinol Laryngol. 2022;131(6):678–682. doi:10.1177/00034894211036844
   Web of Science ®Google Scholar
• Mada PK, Saldaña Koppel DA, Al Shaarani M, Joel Chandranesan AS. Primary cutaneous Aspergillus fumigatus infection in immunocompetent host. BMJ Case Rep. 2020;13(2):e233020. doi:10.1136/bcr-2019-233020
   Google Scholar
• Li L, Hsu SH, Wang C, et al. Characteristics of viral pneumonia in non-HIV immunocompromised and immunocompetent patients: a retrospective cohort study. BMC Infect Dis. 2021;21(1):767. doi:10.1186/s12879-021-06437-5
   Web of Science ®Google Scholar
• Lindell RB, Nishisaki A, Weiss SL, Traynor DM, Fitzgerald JC. Risk of mortality in immunocompromised children with severe sepsis and septic shock. Crit Care Med. 2020;48(7):1026–1033. doi:10.1097/CCM.0000000000004329
   PubMed Web of Science ®Google Scholar
• McCann S, Byrne JL, Rovira M, et al. Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant. 2004;33(5):519–529. doi:10.1038/sj.bmt.1704380
   Web of Science ®Google Scholar
• Zhang J, Du Z, Bi J, et al. Comparison of clinical characteristics and outcomes of pyogenic liver abscess patients < 65 years of age versus ≥ 65 years of age. BMC Infect Dis. 2019;19(1):233. doi:10.1186/s12879-019-3837-2
   Web of Science ®Google Scholar
• Nishikawa M, Yamamoto Y, Kushida S, et al. Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older. DEN Open. 2022;3(1):e167. doi:10.1002/deo2.167
   Google Scholar
• Hernández-Sánchez A, Cabero A, Fonseca M, et al. CT-169 cytokine release syndrome after peripheral blood haploidentical stem cell transplantation with post-transplant cyclophosphamide: time of onset matters. Clin Lymphoma Myeloma Leuk. 2022;22(Suppl 2):S437–S438. doi:10.1016/S2152-2650(22)01653-6
   Google Scholar
• Protus M, Uchytilova E, Indrova V, et al. Sepsis affects kidney graft function and one-year mortality of the recipients in contrast with systemic inflammatory response. Front Med. 2022;9:923524. doi:10.3389/fmed.2022.923524
   Web of Science ®Google Scholar
• Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34(1):15–21. doi:10.1097/01.ccm.0000194535.82812.ba
   PubMed Web of Science ®Google Scholar
• Turkkan S, Beyoglu MA, Sahin MF, Yazicioglu A, Tezer Tekce Y, Yekeler E. COVID-19 in lung transplant recipients: a single-center experience. Transpl Infect Dis. 2021;23(5):e13700. doi:10.1111/tid.13700
   Web of Science ®Google Scholar
• Blanchard F, Charbit J, Van der Meersch G, et al. Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis. Ann Intensive Care. 2020;10(1):58. doi:10.1186/s13613-020-00676-6
   Web of Science ®Google Scholar
• Barlas T, Inci K, Aygencel G, et al. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study. Hematology. 2021;26(1):328–339. doi:10.1080/16078454.2021.1905355
   PubMed Web of Science ®Google Scholar
• Howlader N, Mariotto AB, Besson C, et al. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era. Cancer. 2017;123(17):3326–3334. doi:10.1002/cncr.30739
   PubMed Web of Science ®Google Scholar
• Lugtenburg P, Silvestre AS, Rossi FG, et al. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens. Clin Lymphoma Myeloma Leuk. 2012;12(5):297–305. doi:10.1016/j.clml.2012.06.004
   PubMed Web of Science ®Google Scholar
• Morrison VA, Weller EA, Habermann TM, et al. Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494). Leuk Lymphoma. 2017;58(8):1814–1822. doi:10.1080/10428194.2016.1265111
   PubMed Web of Science ®Google Scholar
• Torres VB, Azevedo LC, Silva UV, et al. Sepsis-associated outcomes in critically ill patients with malignancies. Ann Am Thorac Soc. 2015;12(8):1185–1192. doi:10.1513/AnnalsATS.201501-046OC
   PubMed Web of Science ®Google Scholar
• Marín M, Gudiol C, Castet F, et al. Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era. Clin Transl Oncol. 2019;21(2):187–196. doi:10.1007/s12094-018-1905-5
   PubMed Web of Science ®Google Scholar
• Gudiol C, Tubau F, Calatayud L, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66(3):657–663. doi:10.1093/jac/dkq494
   PubMed Web of Science ®Google Scholar
• Marín M, Gudiol C, Ardanuy C, et al. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection. Clin Microbiol Infect. 2015;21(6):583–590. doi:10.1016/j.cmi.2015.01.029
   PubMed Web of Science ®Google Scholar
• Martinez-Nadal G, Puerta-Alcalde P, Gudiol C, et al. Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance. Clin Infect Dis. 2020;70(6):1068–1074. doi:10.1093/cid/ciz319
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Cohen N, Ma KC, et al. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies. J Infect. 2016;73(4):336–345. doi:10.1016/j.jinf.2016.07.002
   PubMed Web of Science ®Google Scholar
• Gudiol C, Albasanz-Puig A, Cuervo G, Carratalà J. Understanding and managing sepsis in patients with cancer in the era of antimicrobial resistance. Front Med. 2021;8:636547. doi:10.3389/fmed.2021.636547
   Web of Science ®Google Scholar
• Han SB, Kim SB, Shin KH. Risk factors for postoperative pneumonia in patients undergoing Hip fracture surgery: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2022;23(1):553. doi:10.1186/s12891-022-05497-1
   Web of Science ®Google Scholar
• Chen Y, Wang WL, Zhang W, et al. Risk factors and outcomes of carbapenem-resistant Enterobacteriaceae infection after liver transplantation: a retrospective study in a Chinese population. Infect Drug Resist. 2020;13:4039–4045. doi:10.2147/IDR.S278084
   Web of Science ®Google Scholar
• Lanternier F, Amazzough K, Favennec L, et al. Infection in solid organ transplantation: the nationwide “TRANSCRYPTO” study. Transplantation. 2017;101(4):826–830. doi:10.1097/TP.0000000000001503
   PubMed Web of Science ®Google Scholar
• Niu T, Xiao T, Guo L, et al. Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections: cefoperazone-sulbactam associated with resistance and tigecycline increased the mortality. Infect Drug Resist. 2018;11:2021–2030. doi:10.2147/IDR.S169432
   PubMed Web of Science ®Google Scholar
• Tasina E, Haidich AB, Kokkali S, Arvanitidou M. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. Lancet Infect Dis. 2011;11(11):834–844. doi:10.1016/S1473-3099(11)70177-3
   PubMed Web of Science ®Google Scholar
• Daviet F, Guilloux P, Hraiech S, et al. Impact of obesity on survival in COVID-19 ARDS patients receiving ECMO: results from an ambispective observational cohort. Ann Intensive Care. 2021;11(1):157. doi:10.1186/s13613-021-00943-0
   Web of Science ®Google Scholar
• Galvagno SM, Pelekhaty S, Cornachione CR, et al. Does weight matter? Outcomes in adult patients on venovenous extracorporeal membrane oxygenation when stratified by obesity class. Anesth Analg. 2020;131(3):754–761. doi:10.1213/ANE.0000000000004454
   Web of Science ®Google Scholar
• Herrmann J, Lotz C, Karagiannidis C, et al. Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022;26(1):190. doi:10.1186/s13054-022-04053-6
   Web of Science ®Google Scholar